[Modification to the erythrocyte membrane lipids in patients with cardiovascular pathology during balneotherapy].
Erythrocyte phospholipids (FL) composition and their elements polyunsaturated fatty acids of omega-6 and omega-3 type were studied in the course of combined balneotherapy of neurocirculatory dystonia and ischemic heart disease (IHD) patients. The balneological factors promoted FL concentration normalization under positive dynamics in clinical symptoms in 62% of patients with neurocirculatory dystonia. The modulating effect occurred in IHD only in those patients who, in addition to balneotherapy, took alimentary omega-3 fatty acids made of sea products as food additives. The intensity of the FL and fatty acid modification to the end of the treatment was related to the severity of the baseline metabolic abnormalities.
Novgorodtseva
T P
TP
Endakova
E A
EA
Kozycheva
E V
EV
Kitaĭskaia
L S
LS
D000293:Adolescent; D000328:Adult; D000368:Aged; D001452:Balneology; D000072038:Cardiac Rehabilitation; D002318:Cardiovascular Diseases / Q000097:blood* / Q000178:diet therapy; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004042:Dietary Fats, Unsaturated / Q000627:therapeutic use; D004910:Erythrocyte Membrane / Q000378:metabolism*; D015525:Fatty Acids, Omega-3 / Q000097:blood / Q000627:therapeutic use; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated / Q000097:blood; D006801:Humans; D008563:Membrane Lipids / Q000097:blood*; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood
D004042:Dietary Fats, Unsaturated; D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated; D008563:Membrane Lipids; D010743:Phospholipids